Novavax Names John C. Jacobs as New President & Chief Executive Officer

Gaithersburg, MD, January 9, 2023 (PRNewswire) -- Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that John C. Jacobs will succeed Stanley C. Erck as President and Chief Executive Officer and a member of the Board of Directors. The transition will be effective as of January 23, 2023. Mr. Erck will serve as an advisor to the Company for the next fifteen months to enable a smooth transition.

Read full article here.